Severe malaria treatment with rectal artesunate and artemisinin-based combination therapy in remote settings: an effectiveness-implementation hybrid type 3 study protocol (SEMA ReACT). [PDF]
Hachizovu S +19 more
europepmc +1 more source
In- vitro assessment of the anti- malarial potential of Alpha Onocerin; cytotoxicity and hemolytic effect, multi-stage activity and molecular docking. [PDF]
Appiah JA +8 more
europepmc +1 more source
Treatment Failure and Post-Artesunate Delayed Haemolysis in a Returned Traveller From Uganda With Partially Drug-Resistant Severe Plasmodium falciparum Malaria. [PDF]
Travis J +6 more
europepmc +1 more source
Congenital and Neonatal Malaria in Ethiopia: A Narrative Review. [PDF]
Leake Y, Hagos HH, Reta BK.
europepmc +1 more source
Efficacy and safety of artemether-lumefantrine (AL) and artesunate-amodiaquine (ASAQ) for the treatment of uncomplicated Plasmodium falciparum malaria among children 6-59 months in three sentinel sites of Sierra Leone, 2021-2022. [PDF]
Cavros I +19 more
europepmc +1 more source
Cerebral malaria caused by Plasmodium vivax in an afrodescendant adult in Colombia: case report. [PDF]
Sastre-Martínez AD +3 more
europepmc +1 more source
Population pharmacokinetics of fosmidomycin and clindamycin in combination with artesunate for uncomplicated Plasmodium falciparum malaria in Gabonese children and adults. [PDF]
Pfaffendorf C +8 more
europepmc +1 more source
Antimalarial Potency of <i>Tinospora crispa</i> Stem Extract and Artesunate Against <i>Plasmodium berghei</i>: A Study on Combination Therapy. [PDF]
Ounjaijean S, Somsak V.
europepmc +1 more source
Indole Peptidomimetics Show Potent and Selective Activity against Drug-Resistant <i>Plasmodium falciparum</i>. [PDF]
Januário MAP +8 more
europepmc +1 more source
Mechanistic perspectives on antimalarial agents: from FDA-approved drugs to next-generation candidates. [PDF]
Monika, Sharma B, Awasthi SK.
europepmc +1 more source

